Search

Author/Creator van der Poll, T.

1. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. (21st January 2016)

Authors:
Kovari, Helen; Sabin, Caroline A.; Ledergerber, Bruno; Ryom, Lene; Reiss, Peter; Law, Matthew; Pradier, Christian; Dabis, Francois; d'Arminio Monforte, Antonella; Smith, Colette; de Wit, Stephane; Kirk, Ole; Lundgren, Jens D.; Weber, Rainer; Powderly, B.; Shortman, N.; Moecklinghoff, C.; Reilly, ...
Journal:
Open forum infectious diseases
Issue:
Volume 3:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. General, but not myeloid or type II lung epithelial cell, myeloid differentiation factor 88 deficiency abrogates house dust mite induced allergic lung inflammation. (13th October 2016)

Authors:
Anas, A. A.; Yang, J.; Daan de Boer, J.; Roelofs, J. J. T. H.; Hou, B.; de Vos, A. F.; van der Poll, T.
Journal:
Clinical and experimental immunology
Issue:
Volume 187:Number 2(2017:Feb.)
Page Start:
204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study. Issue 2 (February 2021)

Authors:
Smit, Colette; Boyd, Anders; Rijnders, Bart J A; van de Laar, Thijs J W; Leyten, Eliane M; Bierman, Wouter F; Brinkman, Kees; Claassen, Mark A A; den Hollander, Jan; Boerekamps, Anne; Newsum, Astrid M; Schinkel, Janke; Prins, Maria; Arends, Joop E; Op de Coul, Eline L M; van der Valk, Marc; Reiss...
Journal:
Lancet
Issue:
Volume 8:Issue 2(2021)
Page Start:
e96
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study. Issue 3 (March 2023)

Authors:
Verheij, Eveline; Boyd, Anders; Wit, Ferdinand W; Verboeket, Sebastiaan O; Verburgh, Myrthe L; van der Valk, Marc; Schim van der Loeff, Maarten F; Reiss, Peter; Reiss, P.; Wit, F.W.N.M.; van der Valk, M.; Schouten, J.; Kooij, K.W.; van Zoest, R.A.; Verheij, E.; Verboeket, S.O.; Elsenga, B.C.; Pri...
Journal:
Lancet
Issue:
Volume 10:Issue 3(2023)
Page Start:
e164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. OP0085 Safety of long-term (UP TO 6 YEARS) canakinumab therapy (<2, 2−<4 and 4−<8mg/kg) in patients aged <4 to 65 years from beta-confident registry. (12th June 2018)

Authors:
Kuemmerle-Deschner, J.B.; Walker, U.A.; Tilson, H.H.; Hawkins, P.N.; van der Poll, T.; Franke, K.; Speziale, A.; Vritzali, E.; Hoffman, H.H.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
93
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗